Cargando…

Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies

Detalles Bibliográficos
Autores principales:	Xuan, Zixue, Song, Jian, Yang, Quanjun, Huang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679667/ https://www.ncbi.nlm.nih.gov/pubmed/38022560 http://dx.doi.org/10.3389/fimmu.2023.1322220

Ejemplares similares

Editorial: Immunological characteristics of malignant tumors of the hepatobiliary system and identification of immunotherapy targets
por: Zhang, Qiyao, et al.
Publicado: (2023)

Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy
por: Zhang, Er-lei
Publicado: (2023)

Editorial: Advanced Immunization Technologies for Next Generation Vaccines
por: Medaglini, Donata, et al.
Publicado: (2020)

Extracellular Vesicles in Hepatobiliary Malignancies
por: Lapitz, Ainhoa, et al.
Publicado: (2018)

Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response
por: Wang, Kai, et al.
Publicado: (2022)

Editorial: Innovative technologies and materials for treatments of hepatobiliary and pancreatic diseases
por: Li, Di, et al.
Publicado: (2023)

Advances in Targeted Immunotherapy for Hepatobiliary Cancers
por: Ruff, Samantha M., et al.
Publicado: (2022)

Immunomodulatory role of metalloproteinase ADAM17 in tumor development
por: Wang, Kai, et al.
Publicado: (2022)

Editorial: Lysosomal peptidases in tumor immunity
por: Perišić Nanut, Milica, et al.
Publicado: (2023)

Editorial: The Microbiome in Hepatobiliary and Intestinal Disease
por: Hartmann, Phillipp
Publicado: (2022)

Editorial: In vitro cellular technologies for advancing research in anamniote vertebrate immunology
por: Vo, Nguyen T. K., et al.
Publicado: (2023)

Editorial: Evolution of Innate Immunity in Eukarya: Advances and Implications
por: Scholz, Jean L., et al.
Publicado: (2022)

Editorial: Advances in therapeutic strategies of inborn errors of immunity
por: Pilania, Rakesh Kumar, et al.
Publicado: (2023)

Editorial: Innovative 3D technologies in cancer immunity research and therapy
por: Gupta, Deepak, et al.
Publicado: (2023)

Editorial: Immune Response to Cerebral Ischemia: Exploring Mechanisms and Potential Treatment Targets
por: Ye, YingZe, et al.
Publicado: (2021)

Editorial: Recent Advances in Drosophila Cellular and Humoral Innate Immunity
por: Vesala, Laura, et al.
Publicado: (2020)

Editorial: Tumor-promoting immune cells: Cancer immune escape and beyond
por: Domblides, Charlotte, et al.
Publicado: (2023)

Editorial: The role of angiogenesis and immune response in tumor microenvironment of solid tumor
por: Guo, Zichao, et al.
Publicado: (2023)

Editorial: Versatile Roles for B Cells in Tumor Immunity
por: Brossart, Peter
Publicado: (2022)

Editorial: Manipulation of immune-vascular crosstalk in solid tumors
por: Kumar, Vijay
Publicado: (2023)

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy
por: Feron, Olivier, et al.
Publicado: (2023)

Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature
por: Zhang, Chuang, et al.
Publicado: (2021)

Editorial: Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
por: Maghazachi, Azzam A.
Publicado: (2017)

Editorial: Repurposed Drugs as Immune-Modulators to Combat Infectious Diseases
por: Mishra, Bibhuti B., et al.
Publicado: (2022)

Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies
por: Mortara, Lorenzo, et al.
Publicado: (2022)

Editorial: From microbial immunology to microbial therapeutics via targeted delivery technology
por: Puccetti, Matteo, et al.
Publicado: (2022)

Editorial: Ionizing radiation reprograms tumor immune microenvironment by inducing immunogenic cell death
por: Yu, Fei, et al.
Publicado: (2023)

Editorial: Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment
por: Li, Yongsheng, et al.
Publicado: (2018)

Editorial: The impact of the DNA damage response on anti-tumor immunity
por: Chen, Gang, et al.
Publicado: (2022)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Editorial: Role of gut microbiota in diabetes mellitus and tumor immunity
por: Chen, Jingxian, et al.
Publicado: (2023)

Editorial: Immune regulation and intervention in virus-related tumor development
por: Mo, Qinglin, et al.
Publicado: (2023)

Editorial: Organoids, organs-on-chip, nanoparticles and in silico approaches to dissect the tumor-immune dynamics and to unveil the drug resistance mechanisms to therapy in the tumor microenvironment
por: Mattei, Fabrizio, et al.
Publicado: (2023)

Editorial: Targeted Antigen Delivery: Bridging Innate and Adaptive Immunity
por: Manoury, Bénédicte, et al.
Publicado: (2019)

Editorial: Lessons on T-Cells and Immune-Targeting Therapeutics in Coeliac Disease
por: Hardy, Melinda Y., et al.
Publicado: (2021)

Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma
por: Li, Yue, et al.
Publicado: (2022)

Neoplastic signatures: Comparative proteomics of canine hepatobiliary neuroendocrine tumors to normal niche tissue
por: Batts, Tifini L., et al.
Publicado: (2023)

Editorial: Immune dysfunction in nephrotic syndrome - recent advances and new roads ahead
por: Seitz-Polski, Barbara, et al.
Publicado: (2022)

Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
por: Wang, Jing-Hua
Publicado: (2023)

Advances in the Early Detection of Hepatobiliary Cancers
por: Yıldırım, Hasan Çağrı, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dr68t4mok3mmni7bbvs5u46fjk